Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Assets (2016 - 2025)

IGC Pharma (IGC) has disclosed Return on Assets for 15 consecutive years, with 0.73% as the latest value for Q3 2025.

  • Quarterly Return on Assets rose 47.0% to 0.73% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.73% through Sep 2025, up 47.0% year-over-year, with the annual reading at 0.76% for FY2025, 20.0% up from the prior year.
  • Return on Assets for Q3 2025 was 0.73% at IGC Pharma, up from 0.76% in the prior quarter.
  • The five-year high for Return on Assets was 0.25% in Q2 2021, with the low at 1.3% in Q2 2024.
  • Average Return on Assets over 5 years is 0.71%, with a median of 0.67% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -64bps in 2024, then soared 54bps in 2025.
  • Over 5 years, Return on Assets stood at 0.35% in 2021, then crashed by -89bps to 0.67% in 2022, then crashed by -53bps to 1.02% in 2023, then grew by 11bps to 0.91% in 2024, then grew by 20bps to 0.73% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.73%, 0.76%, and 0.8% for Q3 2025, Q2 2025, and Q1 2025 respectively.